What is the recommended dosage of montelukast (Singulair) and fexofenadine (Allegra) for allergic conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Montelukast and Fexofenadine for Allergic Conditions

For allergic conditions, montelukast should be taken at 10mg once daily in the evening for adults and adolescents 15 years and older, while fexofenadine should be taken at 180mg once daily or 60mg twice daily with water. 1, 2

Montelukast (Singulair) Dosing

Adults and Adolescents (15 years and older):

  • Allergic Rhinitis: 10mg once daily, taken in the evening 1
  • Asthma: 10mg once daily, taken in the evening 1
  • Exercise-induced asthma: 10mg at least 2 hours before exercise (not more than once daily) 1

Children:

  • 6-14 years: 5mg chewable tablet once daily 1
  • 2-5 years: 4mg chewable tablet or oral granules once daily 1
  • 6 months-2 years (perennial allergic rhinitis only): 4mg oral granules once daily 1

Fexofenadine (Allegra) Dosing

Adults and Adolescents (12 years and older):

  • Seasonal Allergic Rhinitis: 180mg once daily or 60mg twice daily with water 2
  • Chronic Idiopathic Urticaria: 180mg once daily or 60mg twice daily with water 2

Children (6-11 years):

  • Allergic Rhinitis: 30mg twice daily with water 2
  • Chronic Idiopathic Urticaria: 30mg twice daily with water 2

Dosage Adjustments

Renal Impairment:

  • Montelukast: No dosage adjustment needed 1
  • Fexofenadine: Reduce to 60mg once daily for adults or 30mg once daily for children 2

Clinical Efficacy Considerations

  • Fexofenadine has a rapid onset of action (≤2 hours) and long duration, making it suitable for once-daily administration 3
  • Fexofenadine is particularly effective for symptoms like sneezing, rhinorrhea, and itchy eyes in seasonal allergic rhinitis 3
  • Montelukast is approved for both seasonal and perennial allergic rhinitis and can be particularly beneficial in patients who also have asthma 1, 4

Safety Profile

  • Fexofenadine has a safety profile similar to placebo and does not cause sedation even at doses up to 240mg/day 5
  • Unlike some antihistamines, fexofenadine does not impair driving or psychomotor performance 5
  • Montelukast's common side effects include increased bleeding tendency, drowsiness, and rarely mood-related changes 1
  • Fexofenadine does not cause cardiac QT interval prolongation, making it safer than some older antihistamines 3

Combination Therapy

When monotherapy is insufficient, the combination of montelukast and fexofenadine has shown enhanced efficacy in treating allergic rhinitis symptoms 6. Studies have demonstrated that this combination provides complementary effects by targeting different pathways of the allergic response.

Important Administration Notes

  • Take montelukast at approximately the same time each day 1
  • Montelukast can be taken with or without food 1
  • Fexofenadine should be taken with water 2
  • For montelukast, do not stop taking or lower the dose unless directed by a physician 1

Pitfalls and Caveats

  • Montelukast is not for immediate relief of acute asthma attacks or exercise-induced bronchoconstriction 1
  • Patients taking montelukast should be monitored for neuropsychiatric events including agitation, depression, and suicidal thoughts 1
  • Fexofenadine may be less effective for nasal congestion than for other allergic symptoms 3
  • If a patient with asthma is sensitive to aspirin, they should continue to avoid aspirin while taking montelukast 1

By following these dosage recommendations and administration guidelines, optimal symptom control can be achieved for patients with allergic conditions while minimizing adverse effects.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.